Transfusion Medicine
From the Journals
Small-volume blood sample tubes may reduce anemia and transfusions in intensive care
“Here’s an opportunity to move the needle on reducing anemia in hospitalized patients, where the benefit also doesn’t come at a cost.”
Conference Coverage
In MI with anemia, results may favor liberal transfusion: MINT
This study is “not a home run,” for the primary outcome, however, many of the outcomes tended to be in favor of a liberal transfusion strategy.
From the Journals
Early cryoprecipitate fails to improve trauma hemorrhage outcomes
It is possible that certain patients may have benefited from cryoprecipitate, but they did not receive it promptly or in adequate doses to restore...
Conference Coverage
Using JAK inhibitors for myelofibrosis
Newer options are improving management of cytopenic patients.
Latest News
Guide explains nonsurgical management of major hemorrhage
Bleeding affects everybody in medicine, from family doctors in smaller institutions who work in emergency departments to obstetricians and...
Conference Coverage
Study: Formula-fed extreme preemies need more iron
It’s time to rethink the guidelines on nutritional supplementation for the most premature babies, researchers said.
Conference Coverage
Alloantibody registry would save lives, money
New research supports establishing a national exchange of alloantibody data, to save lives and cut costs in transfusion medicine.
Conference Coverage
Beta-thalassemia: Benefits of gene therapy outweigh costs
Following treatment with betibeglogene autotemcel, some patients went without transfusions for 8 years and counting.
Latest News
Postpartum hemorrhage rates and risk factors rising
Despite increased hemorrhage rates, blood transfusions and peripartum hysterectomies declined in recent years.
News from the FDA/CDC
FDA approves first gene therapy, betibeglogene autotemcel (Zynteglo), for beta-thalassemia
The one-time gene therapy represents a potential cure in which functional copies of the mutated gene are inserted into patients’ hematopoietic...
News
FDA approves first-ever drug for cold agglutinin disease
The first drug to treat a rare anemia has been given the green light by the FDA.